The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Kailash Shantilal Choudhari
AKSHOPTFBR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Kailash Shantilal Choudhari, Promoter & Director of Aksh Optifibre Ltd, sold 24,867 equity shares (0.01% of share capital) through the open market on December 10, 2025. His holding declined marginally from 44,62,925 shares (2.74%) to 44,38,058 shares (2.73%). The disclosure is filed under Regulation 29(2) of SEBI's Substantial Acquisition of Shares & Takeovers (SAST) Regulations, 2011. Persons Acting in Concert (PACs) — including Rohan Rashi Family Trust (3.69%), Mrs. Mona Kailash Choudhari (1.84%), Mr. Rohan Kailash Choudhari (0.09%), and Ms. Rashi Choudhari (0.09%) — collectively hold 93,01,000 shares (5.71%). Combined promoter group stake is roughly 8.44%, well below the 50% mark.
The sale is tiny (just 0.01% of capital) and unlikely to move the stock price or change control dynamics. It signals that the promoter group continues to hold a relatively small stake (under 10%) in the company, leaving it without a majority promoter anchor.